Literature DB >> 16052089

Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men.

Joanne Stekler1, Paul D Swenson, Robert W Wood, H Hunter Handsfield, Matthew R Golden.   

Abstract

HIV-RNA testing may identify individuals with primary HIV infection. Men who have sex with men (MSM) having HIV testing through Public Health, Seattle and King County were screened for primary infection through pooled RNA testing. Eighty-one out of 3525 specimens (2.3%) had detectable antibody and RNA, and seven out of 3439 antibody-negative specimens (0.2%) had HIV RNA. Targeted screening for primary infection through pooled RNA testing in MSM is a useful addition to HIV case finding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052089     DOI: 10.1097/01.aids.0000180105.73264.81

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  54 in total

1.  Integrating acute HIV infection within routine public health surveillance practices in New York City.

Authors:  Sara Bodach; Sarah Braunstein; Marie Antoinette Bernard; Charulata Jain Sabharwal; Adey Tsega; Colin Shepard
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

2.  Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing.

Authors:  Timothy J Sullivan; Pragna Patel; Angela Hutchinson; Steven F Ethridge; Monica M Parker
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

3.  Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests.

Authors:  Daniel J Westreich; Michael G Hudgens; Susan A Fiscus; Christopher D Pilcher
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

4.  Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.

Authors:  Yen T Duong; Yvonne Mavengere; Hetal Patel; Carole Moore; Julius Manjengwa; Dumile Sibandze; Christopher Rasberry; Charmaine Mlambo; Zhi Li; Lynda Emel; Naomi Bock; Jan Moore; Rejoice Nkambule; Jessica Justman; Jason Reed; George Bicego; Dennis L Ellenberger; John N Nkengasong; Bharat S Parekh
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

5.  Operationalizing the Measurement of Seroadaptive Behaviors: A Comparison of Reported Sexual Behaviors and Purposely-Adopted Behaviors Among Men who have Sex with Men (MSM) in Seattle.

Authors:  Christine M Khosropour; Julia C Dombrowski; James P Hughes; Lisa E Manhart; Jane M Simoni; Matthew R Golden
Journal:  AIDS Behav       Date:  2017-10

6.  Evaluation of a Computer-Based Recruitment System for Enrolling Men Who Have Sex With Men Into an Observational HIV Behavioral Risk Study.

Authors:  Christine M Khosropour; Julia C Dombrowksi; James P Hughes; Lisa E Manhart; Matthew R Golden
Journal:  Am J Epidemiol       Date:  2016-09-08       Impact factor: 4.897

7.  Early male partnership patterns, social support, and sexual risk behavior among young men who have sex with men.

Authors:  Sara Nelson Glick; Matthew R Golden
Journal:  AIDS Behav       Date:  2014-08

8.  No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience.

Authors:  Joanne D Stekler; Kenneth Tapia; Janine Maenza; Claire E Stevens; George A Ure; Joshua D O'Neal; Aric Lane; James I Mullins; Robert W Coombs; Sarah Holte; Ann C Collier
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-13       Impact factor: 2.205

9.  Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.

Authors:  Martin Hoenigl; Antoine Chaillon; Sanjay R Mehta; Davey M Smith; Joshua Graff-Zivin; Susan J Little
Journal:  J Infect       Date:  2016-08-11       Impact factor: 6.072

10.  HIV/TB co-infection in mainland China: a meta-analysis.

Authors:  Lei Gao; Feng Zhou; Xiangwei Li; Qi Jin
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.